Figure 1.
Molecular structures of representative cyclin-dependent kinase inhibitors alvocidib (flavopiridol; A), dinaciclib (B), seliciclib (C), and TG02 (D).
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.